ALKBH3 and hepatocellular carcinoma: The half‐life of ALKBH3 mRNA in HCC cells was reduced after ALKBH3‐AS1 knockdown, indicating that ALKBH3‐AS1 maintained the stability of ALKBH3 mRNA.